13F HOLDINGS REPORT
Artal Group S.A.
Quarter ended Q4 2025 · Filed February 12, 2026 · Accession 0001053906-26-000003
Total Value
$714.6M
Positions
2
Other Managers
5
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cava Group Inc | CAVA | 9,507,990 | $558.0M | 78.09% |
| 2 | Lexicon Pharmaceuticals Inc | LXRX | 136,180,481 | $156.6M | 21.91% |